Nutritional Supplement Powder Form Inosine

• Powder: Yes
• Customized: Customized
• Certification: ISO 9001
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Model NO.: LYPH-Inosine
• Grade: Medical Grade
• Coa: Available
• Sample: Available
• CAS No: 58-63-9
• MOQ: 1kg
• Place of Origin: Shaanxi, China
• Storage: Store Cool Dry Place
• Test Method: HPLC UV
• Appearance: White Powder
• Extract Method: Solvent Extraction
• Form: Powder
• Brand: Lyphar
• Size: 100% Pass 80 Mesh
• Mf: C10h12n4o5
• Package: 25kg Per Durm
• Transport Package: 1kg/Bag or 20/25kg/Drum
• Specification: 99%
• Trademark: Lyphar
• Origin: China
• Production Capacity: 300kg

Product Description

Nutritional Supplement Powder Form Inosine 

 

Product Name	Inosine
Molecular Formula	C10H12N4O5
Molecular Weight	268.2261
CAS RegistryNumber	58-63-9
EINECS	200-390-4
Density	2.08g/cm3
Melting point	212-213°C
Boiling point	732.8°C at 760 mmHg
Refractive index	1.879
Flash point	397°C
Water solubility	2.1 g/100 mL (20°C)
Vapour Pressur	1.52E-22mmHg at 25°C

Inosine is the important material of human body, a kind of coenzyme drug widely used in the medicine and the food industry. It can penetrate cell membrane into the cell of body directly, and make the cell in a state of feeblemindedness and anoxia continue to metabolize smoothly. And it can activate caetone acid oxides, and participate the body protein in synthesizing.

1).Used in the treatment of leucopenia and thrombocytopenia.

2).In the treatment of acute hepatitis and chronic hepatitis and liver cirrhosis, hepatic encephalopathy.

3).Used for coronary atherosclerotic heart disease (coronary heart disease), myocardial infarction, rheumatic heart disease, cor pulmonale auxiliary drug use.

4).Used to prevent and mitigate the schistosomiasis prevention drugs caused by the heart and the liver toxicity.

5).Used for eye diseases (central retinal inflammation, optic atrophy) auxiliary drug use.